0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cancer Immunotherapy Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-4S6224
Home | Market Reports | Health| Health Conditions| Cancer
Global Cancer Immunotherapy Market Insights and Forecast to 2028
BUY CHAPTERS

Global Cancer Immunotherapy Market Insights and Forecast to 2028

Code: QYRE-Auto-4S6224
Report
January 2022
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cancer Immunotherapy Market Outlook 2028

The global Cancer Immunotherapy market size is projected to reach USD 135140 million by 2028, from USD 75950 million in 2021, at a CAGR of 8.1% during 2022-2028.

Cancer Immunotherapy Market

Major Trends in Cancer Immunotherapy Market 

Key drivers of the Cancer Immunotherapy market include the growing prevalence of cancer cases and increasing awareness regarding cancer immunotherapies.

The technological advancements in cancer treatment and newer drug usage such as checkpoint inhibitors will fuel the growth of the cancer immunotherapy market during the forecast period. 

The increasing R&D initiatives into the effectiveness of monoclonal antibodies as alternative therapy will propel market growth in the coming years. However, strict government regulations and high product development costs will hamper the market demand. While Lung Cancer segment is altered to an % CAGR throughout this forecast period.

Cancer Immunotherapy

Immunotherapy, also called biologic therapy, is a type of cancer treatment that boosts the body's natural defenses to fight cancer.

Trends Influencing Global Cancer Immunotherapy Market 

Worldwide surge in cancer-related problems

As per WHO about 10 million or 1 in six deaths globally happened due to cancer in 2020. It is a serious public health challenge with the burden expected to rise in the coming years. Lung cancers are the most common type. Cancer immunotherapy has emerged as a way of targeted therapy treatment sessions with improved efficacy and safety standards. It helps in the precise targeting of the cancer cells by boosting the immune system. This is going to bolster the cancer immunotherapy market during the forecast period.

Technological innovations 

Cancer treatment is going through a transition pace due to fast technology changes. Personalized medicine has taken the center stage along with the use of checkpoint inhibitors. Targeted cancer vaccines are being developed that are based on mRNA molecules. These molecules basically instruct immune cells to make proteins against cancer antigens for boosting immunity. Comparing the DNA sequences of healthy and malignant cells enables a deep understanding of the type of cancer mutations that will trigger a strong response from the immune system. The early clinical trials show great promise. This in turn will create lucrative opportunities for the cancer immunotherapy market in the future. The vaccine technology is expected to be cheaper which will further boost the market demand. 

Monoclonal Antibody Research 

MAbs are artificially grown antibodies in laboratories. They are used across the world for treating cancers. Monoclonal antibodies either kill cancer cells directly by triggering the immune system or act on the proteins in immune cells. They can be used in a single or in a variety of ways. Moreover, R&D activities are being carried out for developing conjugated, naked antigen binding or biospecific antibodies. This will create alternative treatment options thereby driving the growth of the cancer immunotherapy market during the forecast period. 

Tough regulations and costly feature

The ongoing clinical trials and research is being carried out under government supervision. This makes it hard for industry players to enter the market. In addition to it, the cost of cancer immunotherapy drugs is expensive and provides an extra burden on the overall healthcare system. These factors will restrict the growth of the cancer immunotherapy market during the reviewed period. 

Cancer Immunotherapy Market Size and Share

China Cancer Immunotherapy market size is valued at US$ million in 2021, while the North America and Europe Cancer Immunotherapy are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.
As for the Europe Cancer Immunotherapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

Based on type, the monoclonal antibodies segment will grow the highest in the cancer immunotherapy market share as MAbs are extensively used as therapies for treating various types of cancer.

Based on application, lung cancer will maintain dominance in the cancer immunotherapy market share owing to the growing burden of lung cancer diseases and the need for early therapy.

Based on region, North America is expected to provide lucrative opportunities for growth in the cancer immunotherapy market share due to rising cancer cases and increasing healthcare spending for treatment along with advanced technologies.

Cancer Immunotherapy Market Insights

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Immunotherapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Immunotherapy market.

Cancer Immunotherapy Market Segment and Scope

Cancer Immunotherapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cancer Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Cancer Immunotherapy Market Segment By Type

  • Monoclonal Antibodies
  • Immune Checkpoint Inhibitors
  • Immune System Modulators
  • Cancer Vaccines

Cancer Immunotherapy Market Segment By Application

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Melanoma
  • Prostate Cancer
  • Others

By Company

  • Amgen
  • AstraZeneca
  • Roche
  • Bayer
  • Bristol-Myers Squibb
  • Eli Lilly
  • Merck
  • Novartis
  • Pfizer

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Cancer Immunotherapy Market Report Coverage

Report Metric

Details

Base Year:

2021

Market by Type

Monoclonal Antibodies, Immune Checkpoint Inhibitors, Immune System Modulators, Cancer Vaccines

Market by Application

Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Others

Forecast Period:

2022 to 2028

No. of Pages:

96

Tables & Figures

115

Segments covered:

Type, Application, Region, Company

Frequently Asked Questions About This Report

1. What would be the forecast period in the Cancer Immunotherapy Market report?

Ans. The forecast period in the Cancer Immunotherapy market report is from 2022 to 2028.

2. What is the estimated market size of Cancer Immunotherapy market by 2028?

Ans. The Cancer Immunotherapy Market size is projected to grow USD US$ 135140 million by 2028.

3. What are the segments by type of Cancer Immunotherapy Market?

Ans. Monoclonal Antibodies, Immune Checkpoint Inhibitors, Immune System Modulators, Cancer Vaccines are the types of Cancer Immunotherapy. 

4. Which region is expected to provide lucrative opportunities for growth in the Cancer Immunotherapy Market?

Ans. North America is expected to provide lucrative opportunities for growth in the cancer immunotherapy market share.

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Immunotherapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monoclonal Antibodies
1.2.3 Immune Checkpoint Inhibitors
1.2.4 Immune System Modulators
1.2.5 Cancer Vaccines
1.3 Market by Application
1.3.1 Global Cancer Immunotherapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Colorectal Cancer
1.3.5 Melanoma
1.3.6 Prostate Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Immunotherapy Market Perspective (2017-2028)
2.2 Cancer Immunotherapy Growth Trends by Region
2.2.1 Cancer Immunotherapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cancer Immunotherapy Historic Market Size by Region (2017-2022)
2.2.3 Cancer Immunotherapy Forecasted Market Size by Region (2023-2028)
2.3 Cancer Immunotherapy Market Dynamics
2.3.1 Cancer Immunotherapy Industry Trends
2.3.2 Cancer Immunotherapy Market Drivers
2.3.3 Cancer Immunotherapy Market Challenges
2.3.4 Cancer Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Immunotherapy Players by Revenue
3.1.1 Global Top Cancer Immunotherapy Players by Revenue (2017-2022)
3.1.2 Global Cancer Immunotherapy Revenue Market Share by Players (2017-2022)
3.2 Global Cancer Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Immunotherapy Revenue
3.4 Global Cancer Immunotherapy Market Concentration Ratio
3.4.1 Global Cancer Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Immunotherapy Revenue in 2021
3.5 Cancer Immunotherapy Key Players Head office and Area Served
3.6 Key Players Cancer Immunotherapy Product Solution and Service
3.7 Date of Enter into Cancer Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Immunotherapy Breakdown Data by Type
4.1 Global Cancer Immunotherapy Historic Market Size by Type (2017-2022)
4.2 Global Cancer Immunotherapy Forecasted Market Size by Type (2023-2028)
5 Cancer Immunotherapy Breakdown Data by Application
5.1 Global Cancer Immunotherapy Historic Market Size by Application (2017-2022)
5.2 Global Cancer Immunotherapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cancer Immunotherapy Market Size (2017-2028)
6.2 North America Cancer Immunotherapy Market Size by Type
6.2.1 North America Cancer Immunotherapy Market Size by Type (2017-2022)
6.2.2 North America Cancer Immunotherapy Market Size by Type (2023-2028)
6.2.3 North America Cancer Immunotherapy Market Share by Type (2017-2028)
6.3 North America Cancer Immunotherapy Market Size by Application
6.3.1 North America Cancer Immunotherapy Market Size by Application (2017-2022)
6.3.2 North America Cancer Immunotherapy Market Size by Application (2023-2028)
6.3.3 North America Cancer Immunotherapy Market Share by Application (2017-2028)
6.4 North America Cancer Immunotherapy Market Size by Country
6.4.1 North America Cancer Immunotherapy Market Size by Country (2017-2022)
6.4.2 North America Cancer Immunotherapy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Cancer Immunotherapy Market Size (2017-2028)
7.2 Europe Cancer Immunotherapy Market Size by Type
7.2.1 Europe Cancer Immunotherapy Market Size by Type (2017-2022)
7.2.2 Europe Cancer Immunotherapy Market Size by Type (2023-2028)
7.2.3 Europe Cancer Immunotherapy Market Share by Type (2017-2028)
7.3 Europe Cancer Immunotherapy Market Size by Application
7.3.1 Europe Cancer Immunotherapy Market Size by Application (2017-2022)
7.3.2 Europe Cancer Immunotherapy Market Size by Application (2023-2028)
7.3.3 Europe Cancer Immunotherapy Market Share by Application (2017-2028)
7.4 Europe Cancer Immunotherapy Market Size by Country
7.4.1 Europe Cancer Immunotherapy Market Size by Country (2017-2022)
7.4.2 Europe Cancer Immunotherapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Immunotherapy Market Size (2017-2028)
8.2 Asia-Pacific Cancer Immunotherapy Market Size by Type
8.2.1 Asia-Pacific Cancer Immunotherapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cancer Immunotherapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cancer Immunotherapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Cancer Immunotherapy Market Size by Application
8.3.1 Asia-Pacific Cancer Immunotherapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cancer Immunotherapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cancer Immunotherapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Cancer Immunotherapy Market Size by Region
8.4.1 Asia-Pacific Cancer Immunotherapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cancer Immunotherapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Immunotherapy Market Size (2017-2028)
9.2 Latin America Cancer Immunotherapy Market Size by Type
9.2.1 Latin America Cancer Immunotherapy Market Size by Type (2017-2022)
9.2.2 Latin America Cancer Immunotherapy Market Size by Type (2023-2028)
9.2.3 Latin America Cancer Immunotherapy Market Share by Type (2017-2028)
9.3 Latin America Cancer Immunotherapy Market Size by Application
9.3.1 Latin America Cancer Immunotherapy Market Size by Application (2017-2022)
9.3.2 Latin America Cancer Immunotherapy Market Size by Application (2023-2028)
9.3.3 Latin America Cancer Immunotherapy Market Share by Application (2017-2028)
9.4 Latin America Cancer Immunotherapy Market Size by Country
9.4.1 Latin America Cancer Immunotherapy Market Size by Country (2017-2022)
9.4.2 Latin America Cancer Immunotherapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Immunotherapy Market Size (2017-2028)
10.2 Middle East & Africa Cancer Immunotherapy Market Size by Type
10.2.1 Middle East & Africa Cancer Immunotherapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cancer Immunotherapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cancer Immunotherapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Cancer Immunotherapy Market Size by Application
10.3.1 Middle East & Africa Cancer Immunotherapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cancer Immunotherapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cancer Immunotherapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Cancer Immunotherapy Market Size by Country
10.4.1 Middle East & Africa Cancer Immunotherapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cancer Immunotherapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Cancer Immunotherapy Introduction
11.1.4 Amgen Revenue in Cancer Immunotherapy Business (2017-2022)
11.1.5 Amgen Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Cancer Immunotherapy Introduction
11.2.4 AstraZeneca Revenue in Cancer Immunotherapy Business (2017-2022)
11.2.5 AstraZeneca Recent Developments
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Cancer Immunotherapy Introduction
11.3.4 Roche Revenue in Cancer Immunotherapy Business (2017-2022)
11.3.5 Roche Recent Developments
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Cancer Immunotherapy Introduction
11.4.4 Bayer Revenue in Cancer Immunotherapy Business (2017-2022)
11.4.5 Bayer Recent Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Cancer Immunotherapy Introduction
11.5.4 Bristol-Myers Squibb Revenue in Cancer Immunotherapy Business (2017-2022)
11.5.5 Bristol-Myers Squibb Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Cancer Immunotherapy Introduction
11.6.4 Eli Lilly Revenue in Cancer Immunotherapy Business (2017-2022)
11.6.5 Eli Lilly Recent Developments
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Cancer Immunotherapy Introduction
11.7.4 Merck Revenue in Cancer Immunotherapy Business (2017-2022)
11.7.5 Merck Recent Developments
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Cancer Immunotherapy Introduction
11.8.4 Novartis Revenue in Cancer Immunotherapy Business (2017-2022)
11.8.5 Novartis Recent Developments
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Cancer Immunotherapy Introduction
11.9.4 Pfizer Revenue in Cancer Immunotherapy Business (2017-2022)
11.9.5 Pfizer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Cancer Immunotherapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Monoclonal Antibodies
    Table 3. Key Players of Immune Checkpoint Inhibitors
    Table 4. Key Players of Immune System Modulators
    Table 5. Key Players of Cancer Vaccines
    Table 6. Global Cancer Immunotherapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Cancer Immunotherapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Cancer Immunotherapy Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Cancer Immunotherapy Market Share by Region (2017-2022)
    Table 10. Global Cancer Immunotherapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Cancer Immunotherapy Market Share by Region (2023-2028)
    Table 12. Cancer Immunotherapy Market Trends
    Table 13. Cancer Immunotherapy Market Drivers
    Table 14. Cancer Immunotherapy Market Challenges
    Table 15. Cancer Immunotherapy Market Restraints
    Table 16. Global Cancer Immunotherapy Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Cancer Immunotherapy Revenue Share by Players (2017-2022)
    Table 18. Global Top Cancer Immunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Immunotherapy as of 2021)
    Table 19. Ranking of Global Top Cancer Immunotherapy Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Cancer Immunotherapy Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Cancer Immunotherapy Product Solution and Service
    Table 23. Date of Enter into Cancer Immunotherapy Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Cancer Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Cancer Immunotherapy Revenue Market Share by Type (2017-2022)
    Table 27. Global Cancer Immunotherapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Cancer Immunotherapy Revenue Market Share by Type (2023-2028)
    Table 29. Global Cancer Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Cancer Immunotherapy Revenue Share by Application (2017-2022)
    Table 31. Global Cancer Immunotherapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Cancer Immunotherapy Revenue Share by Application (2023-2028)
    Table 33. North America Cancer Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Cancer Immunotherapy Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Cancer Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Cancer Immunotherapy Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Cancer Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Cancer Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Cancer Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Cancer Immunotherapy Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Cancer Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Cancer Immunotherapy Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Cancer Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Cancer Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Cancer Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Cancer Immunotherapy Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Cancer Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Cancer Immunotherapy Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Cancer Immunotherapy Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Cancer Immunotherapy Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Cancer Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Cancer Immunotherapy Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Cancer Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Cancer Immunotherapy Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Cancer Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Cancer Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Cancer Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Cancer Immunotherapy Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Cancer Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Cancer Immunotherapy Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Cancer Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Cancer Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Amgen Company Details
    Table 64. Amgen Business Overview
    Table 65. Amgen Cancer Immunotherapy Product
    Table 66. Amgen Revenue in Cancer Immunotherapy Business (2017-2022) & (US$ Million)
    Table 67. Amgen Recent Developments
    Table 68. AstraZeneca Company Details
    Table 69. AstraZeneca Business Overview
    Table 70. AstraZeneca Cancer Immunotherapy Product
    Table 71. AstraZeneca Revenue in Cancer Immunotherapy Business (2017-2022) & (US$ Million)
    Table 72. AstraZeneca Recent Developments
    Table 73. Roche Company Details
    Table 74. Roche Business Overview
    Table 75. Roche Cancer Immunotherapy Product
    Table 76. Roche Revenue in Cancer Immunotherapy Business (2017-2022) & (US$ Million)
    Table 77. Roche Recent Developments
    Table 78. Bayer Company Details
    Table 79. Bayer Business Overview
    Table 80. Bayer Cancer Immunotherapy Product
    Table 81. Bayer Revenue in Cancer Immunotherapy Business (2017-2022) & (US$ Million)
    Table 82. Bayer Recent Developments
    Table 83. Bristol-Myers Squibb Company Details
    Table 84. Bristol-Myers Squibb Business Overview
    Table 85. Bristol-Myers Squibb Cancer Immunotherapy Product
    Table 86. Bristol-Myers Squibb Revenue in Cancer Immunotherapy Business (2017-2022) & (US$ Million)
    Table 87. Bristol-Myers Squibb Recent Developments
    Table 88. Eli Lilly Company Details
    Table 89. Eli Lilly Business Overview
    Table 90. Eli Lilly Cancer Immunotherapy Product
    Table 91. Eli Lilly Revenue in Cancer Immunotherapy Business (2017-2022) & (US$ Million)
    Table 92. Eli Lilly Recent Developments
    Table 93. Merck Company Details
    Table 94. Merck Business Overview
    Table 95. Merck Cancer Immunotherapy Product
    Table 96. Merck Revenue in Cancer Immunotherapy Business (2017-2022) & (US$ Million)
    Table 97. Merck Recent Developments
    Table 98. Novartis Company Details
    Table 99. Novartis Business Overview
    Table 100. Novartis Cancer Immunotherapy Product
    Table 101. Novartis Revenue in Cancer Immunotherapy Business (2017-2022) & (US$ Million)
    Table 102. Novartis Recent Developments
    Table 103. Pfizer Company Details
    Table 104. Pfizer Business Overview
    Table 105. Pfizer Cancer Immunotherapy Product
    Table 106. Pfizer Revenue in Cancer Immunotherapy Business (2017-2022) & (US$ Million)
    Table 107. Pfizer Recent Developments
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cancer Immunotherapy Market Share by Type: 2021 VS 2028
    Figure 2. Monoclonal Antibodies Features
    Figure 3. Immune Checkpoint Inhibitors Features
    Figure 4. Immune System Modulators Features
    Figure 5. Cancer Vaccines Features
    Figure 6. Global Cancer Immunotherapy Market Share by Application: 2021 VS 2028
    Figure 7. Lung Cancer Case Studies
    Figure 8. Breast Cancer Case Studies
    Figure 9. Colorectal Cancer Case Studies
    Figure 10. Melanoma Case Studies
    Figure 11. Prostate Cancer Case Studies
    Figure 12. Others Case Studies
    Figure 13. Cancer Immunotherapy Report Years Considered
    Figure 14. Global Cancer Immunotherapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Cancer Immunotherapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Cancer Immunotherapy Market Share by Region: 2021 VS 2028
    Figure 17. Global Cancer Immunotherapy Market Share by Players in 2021
    Figure 18. Global Top Cancer Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Immunotherapy as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Cancer Immunotherapy Revenue in 2021
    Figure 20. North America Cancer Immunotherapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. North America Cancer Immunotherapy Market Size Market Share by Type (2017-2028)
    Figure 22. North America Cancer Immunotherapy Market Size Market Share by Application (2017-2028)
    Figure 23. North America Cancer Immunotherapy Market Size Share by Country (2017-2028)
    Figure 24. United States Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Canada Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Cancer Immunotherapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 27. Europe Cancer Immunotherapy Market Size Market Share by Type (2017-2028)
    Figure 28. Europe Cancer Immunotherapy Market Size Market Share by Application (2017-2028)
    Figure 29. Europe Cancer Immunotherapy Market Size Share by Country (2017-2028)
    Figure 30. Germany Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. France Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. U.K. Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Italy Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Russia Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Nordic Countries Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Cancer Immunotherapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 37. Asia Pacific Cancer Immunotherapy Market Size Market Share by Type (2017-2028)
    Figure 38. Asia Pacific Cancer Immunotherapy Market Size Market Share by Application (2017-2028)
    Figure 39. Asia Pacific Cancer Immunotherapy Market Size Share by Region (2017-2028)
    Figure 40. China Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Japan Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. South Korea Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Southeast Asia Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. India Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Australia Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 46. Latin America Cancer Immunotherapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Latin America Cancer Immunotherapy Market Size Market Share by Type (2017-2028)
    Figure 48. Latin America Cancer Immunotherapy Market Size Market Share by Application (2017-2028)
    Figure 49. Latin America Cancer Immunotherapy Market Size Share by Country (2017-2028)
    Figure 50. Mexico Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Brazil Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Cancer Immunotherapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 53. Middle East and Africa Cancer Immunotherapy Market Size Market Share by Type (2017-2028)
    Figure 54. Middle East and Africa Cancer Immunotherapy Market Size Market Share by Application (2017-2028)
    Figure 55. Middle East and Africa Cancer Immunotherapy Market Size Share by Country (2017-2028)
    Figure 56. Turkey Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. UAE Cancer Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. Amgen Revenue Growth Rate in Cancer Immunotherapy Business (2017-2022)
    Figure 60. AstraZeneca Revenue Growth Rate in Cancer Immunotherapy Business (2017-2022)
    Figure 61. Roche Revenue Growth Rate in Cancer Immunotherapy Business (2017-2022)
    Figure 62. Bayer Revenue Growth Rate in Cancer Immunotherapy Business (2017-2022)
    Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Cancer Immunotherapy Business (2017-2022)
    Figure 64. Eli Lilly Revenue Growth Rate in Cancer Immunotherapy Business (2017-2022)
    Figure 65. Merck Revenue Growth Rate in Cancer Immunotherapy Business (2017-2022)
    Figure 66. Novartis Revenue Growth Rate in Cancer Immunotherapy Business (2017-2022)
    Figure 67. Pfizer Revenue Growth Rate in Cancer Immunotherapy Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

RELATED REPORTS

Global Hurthle Cell Carcinoma Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-35B1140
Sun Feb 11 00:00:00 UTC 2024

Add to Cart

Global Oncology Based Molecular Diagnostics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-6P7589
Thu Feb 08 00:00:00 UTC 2024

Add to Cart

Global Internal Radiation Therapy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-17G14298
Thu Feb 08 00:00:00 UTC 2024

Add to Cart

Global External beam Radiation Therapy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-5C14164
Thu Feb 08 00:00:00 UTC 2024

Add to Cart